Applied Therapeutics, Inc. (APLT)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation

Ask a question about Applied Therapeutics, Inc. (APLT)

Company Performance

Current Price

as of Oct 16, 2024

$8.79

P/E Ratio

N/A

Market Cap

$1.01B

Description

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.

Metrics

Overview

HQNew York, NY
SectorHealth Technology
IndustryPharmaceuticals: Major
TickerAPLT
Price$8.795-3.77%

Trading Information

Market Cap$1.01B
Float74.88%
Average Daily Volume (1m)2,857,467
Average Daily Volume (3m)2,477,780
EPS-$1.42

Company

Revenue$9.99M
Rev Growth (1yr)N/A
Net Income$2.90M
Gross Margin15.28%
EBITDA Margin-14,109.72%
EBITDA-$20.32M

EV$589.69M
EV/Revenue59.01
P/EN/A
P/S134.12
P/B13.95

Documents

Factset Street Account

Applied Therapeutics reports Q3 EPS ($0.47) vs year-ago ($0.40) ($2.31, 0.00) (2023-11-09T12:34:41Z)

Applied Therapeutics enter exchange agreement with Venrock Healthcare Capital Partners - 8-K ($2.42, 0.00) (2023-10-13T20:45:56Z)

Applied Therapeutics appoints Les Funtleyder as CFO, effective as of 20-Nov-23 - 8-K ($1.97, 0.00) (2023-11-17T21:15:24Z)

Factset

Factset Business Description